Pharmaceutical Preparations · DE · CIK 879407
Arrowhead Pharmaceuticals develops medicines that silence disease-causing genes using RNA interference
Comparable business profile · signals at a glance
In the 90 days to Mar 5, 2026: 8 sold $33.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 5, 2026 | Hamilton James CChief Medical Officer | Sell | 10,000 | $64.19 | $642K |
| Jan 5, 2026 | Hamilton James CChief Medical Officer | Sell | 14,792 | $63.01 | $932K |
| Jan 5, 2026 | O'Brien PatrickCOO | Sell | 13,451 | $62.96 | $847K |
| Jan 5, 2026 | Hamilton James CChief Medical Officer | Sell | 12,711 | $63.95 | $813K |
| Jan 5, 2026 | O'Brien PatrickCOO | Sell | 11,842 | $63.84 | $756K |
| Jan 5, 2026 | O'Brien PatrickCOO | Sell | 6,164 | $62.23 | $384K |
| Jan 5, 2026 | Hamilton James CChief Medical Officer | Sell | 6,090 | $62.28 | $379K |
| Jan 5, 2026 | O'Brien PatrickCOO | Sell | 5,873 | $62.91 | $369K |
| Jan 5, 2026 | Hamilton James CChief Medical Officer | Sell | 4,625 | $61.24 | $283K |
| Jan 5, 2026 | O'Brien PatrickCOO | Sell | 4,368 | $61.20 | $267K |
| Jan 5, 2026 | O'Brien PatrickCOO | Sell | 2,700 | $64.44 | $174K |
| Jan 5, 2026 | O'Brien PatrickCOO | Sell | 2,336 | $64.04 | $150K |
| Jan 5, 2026 | Hamilton James CChief Medical Officer | Sell | 1,200 | $64.49 | $77K |
| Jan 5, 2026 | O'Brien PatrickCOO | Sell | 900 | $66.01 | $59K |
| Jan 5, 2026 | O'Brien PatrickCOO | Sell | 900 | $62.25 | $56K |
| Jan 5, 2026 | O'Brien PatrickCOO | Sell | 600 | $61.12 | $37K |
| Jan 5, 2026 | Hamilton James CChief Medical Officer | Sell | 437 | $65.97 | $29K |
| Jan 5, 2026 | O'Brien PatrickCOO | Sell | 313 | $68.00 | $21K |
| Jan 5, 2026 | Hamilton James CChief Medical Officer | Sell | 309 | $68.00 | $21K |
| Jan 5, 2026 | O'Brien PatrickCOO | Sell | 46 | $68.00 | $3K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.